148 related articles for article (PubMed ID: 16286025)
1. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.
Curiel L; Souchon R; Rouvière O; Gelet A; Chapelon JY
Ultrasound Med Biol; 2005 Nov; 31(11):1461-8. PubMed ID: 16286025
[TBL] [Abstract][Full Text] [Related]
2. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
3. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance-guided high-intensity ultrasound ablation of the prostate.
Pauly KB; Diederich CJ; Rieke V; Bouley D; Chen J; Nau WH; Ross AB; Kinsey AM; Sommer G
Top Magn Reson Imaging; 2006 Jun; 17(3):195-207. PubMed ID: 17414077
[TBL] [Abstract][Full Text] [Related]
5. Principles and results of high-intensity focused ultrasound for localized prostate cancer.
Colombel M; Gelet A
Prostate Cancer Prostatic Dis; 2004; 7(4):289-94. PubMed ID: 15452554
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
7. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
[TBL] [Abstract][Full Text] [Related]
10. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
[TBL] [Abstract][Full Text] [Related]
11. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
[TBL] [Abstract][Full Text] [Related]
12. High-intensity focused ultrasound: where are we and where to from here?
Williams AK; Martínez CH; Chalasani V; Chin J
Expert Rev Anticancer Ther; 2010 Jan; 10(1):33-40. PubMed ID: 20014883
[TBL] [Abstract][Full Text] [Related]
13. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
14. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
[TBL] [Abstract][Full Text] [Related]
15. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
16. Treatment of localized prostate cancer using high-intensity focused ultrasound.
Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
[TBL] [Abstract][Full Text] [Related]
17. Sector-switching sonication strategy for accelerated HIFU treatment of prostate cancer: in vitro experimental validation.
Petrusca L; Salomir R; Brasset L; Chavrier F; Cotton F; Chapelon JY
IEEE Trans Biomed Eng; 2010 Jan; 57(1):17-23. PubMed ID: 19709958
[TBL] [Abstract][Full Text] [Related]
18. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
